Showing results (1-10 of 5) with videos related to
Sort By:
Pageof 1
Pancreas|November 27, 2014
Perfusion computed tomography as functional biomarker in randomized run-in study of bevacizumab and everolimus in well-differentiated neuroendocrine tumorsJames C Yao, Alexandria T Phan, Kenneth Hess, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2008
Efficacy of RAD001 (everolimus) and octreotide LAR in advanced low- to intermediate-grade neuroendocrine tumors: results of a phase II studyJames C Yao, Alexandria T Phan, David Z Chang, et al.Journal of Neuro-Oncology|April 11, 2015
An open-label, two-stage, phase II study of bevacizumab and lapatinib in children with recurrent or refractory ependymoma: a collaborative ependymoma research network study (CERN)Mariko DeWire, Maryam Fouladi, David C Turner, et al.Neuro-Oncology Advances|January 11, 2021
A validated integrated clinical and molecular glioblastoma long-term survival-predictive nomogramSherise D Ferguson, Tiffany R Hodges, Nazanin K Majd, et al.JCI Insight|July 30, 2020
Profiling of patients with glioma reveals the dominant immunosuppressive axis is refractory to immune function restorationMartina Ott, Karl-Heinz Tomaszowski, Anantha Marisetty, et al.Pageof 1